Solara Active Pharma Sciences has received approval from board of directors to sell 100% shareholding in SeQuent Penems. The board of directors of the company at its meeting held on March 25, 2024 approved the same.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.